People news

Share this article:
Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, announced that John Knopf, Ph.D., has been named as CEO. Knopf, a founder of Acceleron, has served as the EVP of corporate development and recently, as president, before being unanimously elected by the board as CEO. Prior to co-founding Acceleron, Knopf was formerly site head of the Wyeth Research facilities in Cambridge, MA and VP of metabolic and respiratory disease until 2002. Knopf was also a key scientist at Genetics Institute from 1982 to 1998, where he participated in the development of pioneering biopharmaceutical products and helped establish Genetics Institute as a premier biopharmaceutical company. He also established a structure-based small molecule discovery group at Genetics Institute.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions